Dr. Michal Mego is the Head of the 2nd Department of Medical Oncology, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, and works as a Head of Translational Research Unit, National Cancer Institute, Bratislava since 2010. He completed his medical studies at the Faculty of Medicine of Comenius University in Bratislava in 2001. From 2004 to 2007 he studied at the Vienna School of Clinical Research and Vienna Medical University and graduated the studies with a Postgraduate Diploma in Clinical Research in 2007. He was board-certified in Medical Oncology at Slovak Medical University in 2006 and he gained the European Certificate in Medical Oncology in 2005 (ESMO Examination). He obtained his Ph.D. in Oncology from the Cancer Research Institute, Slovak Academy of Sciences, Bratislava in 2006. Dr. Mego has received many honors and awards, including the Young Investigator Travel Grant Award (2nd place) (2013), the Prize of the Minister of Education of Slovakia for Science and Technology for 2011, AACR Translational Research Scholar-in-Training Award in 2009. He is the author of the patent (PCT/US2011/028049) for a novel method for the detection of circulating tumor cells (CTCs) in blood. He is the first author or co-author of more than 400 articles, including more than 200 peer-reviewed articles in the Pubmed database and more than 3000 citations.